Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Cooper

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Pharmacoepidemiology and Drug Safety|April 3, 2008
Developing tools for the safety specification in risk management plans: lessons learned from a pilot projectAndrew J P Cooper, Sally Lettis, Charlotte L Chapman, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituentJ E Cobb, S G Blanchard, E G Boswell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 1999
A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiationJ L Oberfield, J L Collins, C P Holmes, et al.
Journal of Medicinal Chemistry|June 8, 2000
Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structuresD R Bolin, A L Swain, R Sarabu, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Pharmacoepidemiology and Drug Safety|April 3, 2008
Developing tools for the safety specification in risk management plans: lessons learned from a pilot projectAndrew J P Cooper, Sally Lettis, Charlotte L Chapman, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituentJ E Cobb, S G Blanchard, E G Boswell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 1999
A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiationJ L Oberfield, J L Collins, C P Holmes, et al.
Journal of Medicinal Chemistry|June 8, 2000
Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structuresD R Bolin, A L Swain, R Sarabu, et al.
Pageof 5